VRBPAC recommends addition of Omicron-component to future boosters
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaProduct LifecycleRegulatory NewsFerdous Al-FaruqueBiologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaProduct Lifecycle